SAFE-DCB U.S. Registry

SAFE-DCB U.S. Registry

Objective

The purpose of this patient registry is to assess the safety and usage of the Lutonix® DCB PTA catheter. Patients in this study are those that have a blockage in their superficial femoral artery (SFA) (the artery which runs the length of the thigh) or popliteal artery (the artery running from lower thigh to knee) that is treated with the Lutonix® Drug Coated Balloon. The Lutonix® DCB PTA catheter has been approved by the U.S. Food and Drug Administration (FDA).   

Principal Investigator(s)
Eric Dippel

Clinical Trial Categories

  • Cardiac Research
Sponsor(s)
Bard Peripheral Vascular, Inc.
Contact
Genesis Research at 563-421-3941

Location

  • Medical Center, East Rusholme Street
    1227 East Rusholme Street
    Davenport, IA 52803
    Main: 563-421-1000

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email